When Will This Pandemic End?
When Will This Pandemic End?
And other questions you have about Omicron and the pandemic
Gladstone Experts COVID-19 Virology Greene Lab Ott Lab Roan Lab1 - 15 of 23 Results Clear All
And other questions you have about Omicron and the pandemic
Gladstone Experts COVID-19 Virology Greene Lab Ott Lab Roan LabTime—The Omicron variant of SARS-CoV-2 has spread around the world at an alarming rate, but some scientists think the variant might actually be a sign of hope. Nadia Roan explains that widespread infection may lead to widespread immunity, which could help turn the pandemic virus into an endemic virus. Warner Greene posits that the best-case scenario is that the virus will weaken, continuing to spread but without causing severe disease.
Gladstone Experts COVID-19 Virology Greene Lab Roan LabGladstone virologists answer your most pressing questions about the latest variant of COVID-19
Gladstone Experts COVID-19 Virology Greene Lab Ott Lab Roan LabSan Francisco Chronicle—The omicron variant of SARS-CoV-2 is spreading rapidly, but it may not be a reason for panic. Nadia Roan explains that our immune system’s cellular response to the vaccines should hold up well against the omicron variant. In addition, Warner Greene predicts that if the variant spreads rapidly but causes just mild disease, it might actually help establish immunity globally, protecting people in places where vaccine access has been limited.
Gladstone Experts COVID-19 Greene Lab Roan LabResearchers at Gladstone Institutes focus on innovative strategies that could finally allow people living with HIV to stop taking daily medications
Gladstone Experts HIV/AIDS Virology Greene Lab Ott Lab Roan Lab Weinberger LabSan Francisco Chronicle—The emerging Omicron variant of SARS-CoV-2 features several mutations in its spike protein that in theory could make it resistant to current vaccines. But Associate Investigator Nadia Roan, PhD, explains that current vaccines will still protect against Omicron, as they elicit a variety of antibodies and immune T cells that target non-mutated areas of spike.
Gladstone Experts COVID-19 Virology Roan LabSan Francisco Chronicle—Associate Investigator Nadia Roan, PhD, comments on a potentially new type of COVID-19 vaccine that would fight the virus at its points of entry—the nose, throat, or lungs—and may provide even better protection than current shots in the arm.
Gladstone Experts COVID-19 Virology Roan LabSan Francisco Chronicle—Associate Investigator Nadia Roan, PhD, explains that people who receive COVID-19 vaccination after having had the disease harbor special immune cells that may provide stronger and more durable protection against future infections.
Gladstone Experts COVID-19 Virology Roan LabGladstone researchers studied how T cells respond to COVID-19 vaccines over the weeks following immunization
News Release Research (Publication) COVID-19 Virology Roan LabJason Neidleman shares how his work on HIV has been used to better understand COVID-19 and why he thinks everyone should get vaccinated
Profile COVID-19 HIV/AIDS Roan LabUCSF News—Associate Investigator Nadia Roan, PhD, explains why the coronavirus delta variant is so infectious, how antibodies and T cells contribute to immunity, and why vaccinated people should still wear masks.
Gladstone Experts COVID-19 Virology Roan LabCOVID vaccines protect from serious illness but may not prevent vaccinated people from transmitting the delta variant. Gladstone Associate Investigator Nadia Roan, PhD, says that wearing a mask adds to the protective effect of vaccines and helps reduce the circulation of the highly contagious delta variant.
COVID-19 Virology Roan LabGladstone scientists have uncovered T-cell signatures that may help understand why some people succumb to severe COVID-19 while others recover
News Release Research (Publication) COVID-19 Virology Roan Lab Single CellGladstone researchers have identified the blood cells most likely to be targeted by HIV during a real-life infection
News Release Research (Publication) HIV/AIDS Virology Roan LabSan Francisco Chronicle—Associate Investigator Nadia Roan, PhD, comments on recent findings by her group and others that COVID-19 patients retain immune cells against the new coronavirus for several months after infection, which bodes well for the ability of vaccines to provide lasting protection against the disease.
Gladstone Experts COVID-19 Virology Roan Lab